At a glance
ClinicalIndex Comparison RecordN/ACompleted· 41 enrolled
Drug / intervention
Aesthetic Microneedling Treatmentprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Single-Center Trial to Evaluate the Efficacy and Tolerability of SkinPen on Male and Female Subjects' Acne Scars on the Face and/or Back
In Brief
A clinical study evaluating Aesthetic Microneedling Treatment for Atrophic Acne Scar. Completed, enrolled 41 participants across 1 site.
Detailed Summary
This single-center, clinical trial will take place over a 90 day course followed by 1-month and 6-month post treatment visits to assess the efficacy and tolerability of the SkinPen device when used on both men and women on the face and/or back.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtrophic Acne Scar
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartDec 2015
First PostedJan 2016
Primary CompletionDec 2016
Study CompletionJul 2017
TodayJul 2026
First PostedJan 6, 2016
Enrollment StartDec 1, 2015
Primary CompletionDec 1, 2016
Study CompletionJul 25, 2017
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 10.5 years ago
Interventions
Aesthetic Microneedling Treatmentprocedure
Treatment of acne scars on the face and/or back at needle depth settings ranging between 0.25 mm to 2.0 mm, depending on severity and location of scarring.